CG Oncology
Manufacturing · Texas, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
3000 Pegasus Park Dr Ste 1640, Dallas, T...Phone Number
(949) 409-3700Website
www.cgoncology.comRevenue
$6.2 MillionStock Symbol
CGONIndustry
About CG Oncology
CG Oncology is a late-stage pharmaceutical company dedicated to developing and delivering bladder-sparing immunotherapies for bladder cancer patients. The company focuses on innovative treatments, particularly its investigational drug Cretostimogene grenadenorepvec, which targets non-muscle invasive bladder cancer. CG Oncology aims to enhance the quality of life for patients through its pioneering work and commitment to addressing unmet medical needs. Their intended clients include patients suffering from bladder cancer and healthcare professionals involved in cancer treatment.Explore more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: CGONShow moreCG Oncology Org Chart
Compare Similar Companies to CG Oncology
Compare insights from companies similar to CG Oncology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
CG Oncology Tech Stack
A closer look at the technologies used by CG Oncology
See more technologies
Top Manufacturing Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding CG Oncology
Sign Up For FreeTo access detailed company insights
CG Oncology is a late-stage pharmaceutical company dedicated to developing and delivering bladder-sparing immunotherapies for bladder cancer patients. The company focuses on innovative treatments, particularly its investigational drug Cretostimogene grenadenorepvec, which targets non-muscle invasive bladder cancer. CG Oncology aims to enhance the q... Read More

